|
|||||
|
|
Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies. |
|
| Authors: | V P Khatri T A Fehniger R A Baiocchi F Yu M H Shah D S Schiller M Gould R T Gazzinelli Z P Bernstein M A Caligiuri |
| Affiliation: | Division of Surgery, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. |
| Abstract: | |
| Keywords: | |